[The sensitivity improvement of HBx+HepG2 to CDDP with PD98059].
Li
Yu-long
YL
Institute of Digestive Diseases, Zhengzhou University, Zhengzhou 450003, China.
Chen
Xiang-yu
XY
Duan
Fang-ling
FL
D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000821:virology*; D002945:Cisplatin / Q000494:pharmacology*; D004357:Drug Synergism; D005419:Flavonoids / Q000494:pharmacology*; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000821:virology*; D015534:Trans-Activators; D014407:Tumor Cells, Cultured; D054334:Viral Regulatory and Accessory Proteins / Q000187:drug effects*
D005419:Flavonoids; D015534:Trans-Activators; D054334:Viral Regulatory and Accessory Proteins; C057628:hepatitis B virus X protein; D002945:Cisplatin; C093973:2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one